Journal
NANOMEDICINE
Volume 12, Issue 10, Pages 1135-1151Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2017-0430
Keywords
biodistribution; furin; liposomes; peptide; pharmacokinetic; rhabdomyosarcoma; targeting; vincristine
Funding
- Phospholipid Research Center, Heidelberg, Germany
- Swiss Cancer League
- Olga Mayenfisch Foundation
- Monika Anna Muller Grant
- Krebsliga Zurich
Ask authors/readers for more resources
Aim: Our goal was to improve vincristine (VCR) based rhabdomyosarcoma (RMS) therapy by encapsulating the drug into liposomes. A targeting strategy was attempted to enhance tumor accumulation. Materials & methods: VCR was loaded in control and peptide-decorated liposomes via an active method. The interaction of an RMS-specific peptide with the presumed target furin and the cellular uptake of both liposomal groups were studied in vitro. Pharmacokinetics and biodistribution of VCR-containing liposomes were assessed in an RMS xenograft mouse model. Results: Liposomes ensured high VCR concentration in plasma and in the tumor. Peptide-decorated liposomes showed modest uptake in RMS cells. Conclusion: The investigated peptide-modified liposomal formulation may not be optimal for furin-mediated RMS targeting. Nevertheless, VCR-loaded liposomes could serve as a delivery platform for experimental RMS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available